Ledger.Open graph →

SEC Form D · Amendment · filed April 10, 2020

CRISPR Therapeutics AG

Offering

$1.0M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

Zug, V8

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

John Greene · Zug, V8Director Samarth Kulkarni · Zug, V8Exec · Director Tony Ho · Zug, V8Exec Bradley Bolzon · Zug, V8Director Ali Behbahani · Zug, V8Director Lawrence Klein · Zug, V8Exec Simeon George · Zug, V8Director Michael Tomsicek · Zug, V8Exec James Kasinger · Zug, V8Exec Katherine High · Zug, V8Director Sebastian Caliri · AUSTIN, TXDirector Burke Wise · NEW YORK, NYDirector Alexander Harrington · New York, NYDirector Justin C. Valley · Lake Oswego, ORExec Henry Russell · Sheridan, WYExec Trinda A. Blackmore · Grand Cayman, Cayman IslandsDirector Ian Sheridan · Boston, MAExec Christian Klacko · Boston, MAExec · Director John Reeves · Sheridan, WYDirector Foy H. Tatum · Montgomery, ALExec Rodger Novak · Basel, V8Exec · Director D. A. Tatman Ii · NASHVILLE, TNExec Elisa Zhang · Cedar City, UTDirector Ady N. Adefris · Quarry Bay, Hong KongExec · Director Scott Shipman · Vancouver, British Columbia, CanadaExec Justin Butler · San Francisco, CADirector Ying Wang · Mountain View, CAExec Lynne Winings · Cleveland, OHDirector Dan Bergrin · Cleveland, OHDirector Nolan T. Altman · Oceanside Drive, NYDirector Terry Wheeler · ROSEVILLE, CAExec Rodger Novak · Basel, V8Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗